Advanced search
Publication Cover
Epigenomics Volume 3, 2011 - Issue 6
Submit an article Journal homepage
299
Views
0
CrossRef citations to date
0
Altmetric
Review

miRNA Therapeutics: Delivery and Biological Activity of Peptide Nucleic Acids Targeting miRNAs

Enrica Fabbri1 Department of Biochemistry&Molecular Biology, University of Ferrara, Via Fossato di Mortara n.741, 44121Ferrara, ItalyView further author information
,
Eleonora Brognara1 Department of Biochemistry&Molecular Biology, University of Ferrara, Via Fossato di Mortara n.741, 44121Ferrara, ItalyView further author information
,
Monica Borgatti1 Department of Biochemistry&Molecular Biology, University of Ferrara, Via Fossato di Mortara n.741, 44121Ferrara, ItalyView further author information
,
Ilaria Lampronti1 Department of Biochemistry&Molecular Biology, University of Ferrara, Via Fossato di Mortara n.741, 44121Ferrara, ItalyView further author information
,
Alessia Finotti1 Department of Biochemistry&Molecular Biology, University of Ferrara, Via Fossato di Mortara n.741, 44121Ferrara, ItalyView further author information
,
Nicoletta Bianchi1 Department of Biochemistry&Molecular Biology, University of Ferrara, Via Fossato di Mortara n.741, 44121Ferrara, ItalyView further author information
,
Stefano Sforza2 Department of Organic&Industrial Chemistry, University of Parma, Parma, ItalyView further author information
,
Tullia Tedeschi2 Department of Organic&Industrial Chemistry, University of Parma, Parma, ItalyView further author information
,
Alex Manicardi2 Department of Organic&Industrial Chemistry, University of Parma, Parma, ItalyView further author information
,
Rosangela Marchelli2 Department of Organic&Industrial Chemistry, University of Parma, Parma, ItalyView further author information
,
Roberto Corradini2 Department of Organic&Industrial Chemistry, University of Parma, Parma, ItalyView further author information
&
Roberto Gambari1 Department of Biochemistry&Molecular Biology, University of Ferrara, Via Fossato di Mortara n.741, 44121Ferrara, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 733-745 | Published online: 25 Nov 2011

References

  • Nielsen PE , EgholmM, BergRH, BuchardtO. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science254 , 1497–1500 (1991).
  • Demidov VV , Frank-KamenetskiiMD. Sequence-specific targeting of duplex DNA by peptide nucleic acids via triplex strand invasion. Methods23 , 108–122 (2001).
  • Gambari R . Peptide-nucleic acids (PNAs). A tool for the development of gene expression modifiers. Curr. Pharm. Des.7 , 1839–1862 (2001).
  • Paulasova P , PellestorF. The peptide nucleic acids (PNAs). A new generation of probes for genetic and cytogenetic analyses. Ann. Genet.47 , 349–358 (2004).
  • Nielsen PE . Targeting double stranded DNA with peptide nucleic acid (PNA). Curr. Med. Chem.8 , 545–550 (2001).
  • Good L , NielsenPE. Progress in developing PNA as a gene-targeted drug. Antisense Nucleic Acid Drug Dev.7 , 431–437 (1997).
  • Marin VL , RoyS, ArmitageBA. Recent advances in the development of peptide nucleic acid as a gene-targeted drug. Expert Opin. Biol. Ther.4 , 337–348 (2004).
  • Nielsen PE . Antisense peptide nucleic acids. Curr. Opin. Mol. Ther.2 , 282–287 (2002).
  • Soomets U , HällbrinkM, LangelU. Antisense properties of peptide nucleic acids. Front. Biosci.4 , D782–D786 (1999).
  • Ray A , NordénB. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J.14 , 1041–1060 (2000).
  • Fabani MM , GaitMJ. miR-122 targeting with LNA/2´-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA14 , 336–346 (2008).
  • Fabani MM , Abreu-GoodgerC, WilliamsD et al. Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Res. 38 , 4466–4475 (2010).
  • Ivanova GD , FabaniMM, ArzumanovAA et al. PNA-peptide conjugates as intracellular gene control agents. Nucleic Acids Symp. Ser. (Oxford) 52 , 31–32 (2008).
  • Torres AG , FabaniMM, VigoritoE, GaitMJ. MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved northern-blot-based method for miRNA detection. RNA17(5) , 933–943 (2011).
  • Oh SY , JuY, KimS, ParkH. PNA-based antisense oligonucleotides for microRNAs inhibition in the absence of a transfection reagent. Oligonucleotides20(5) , 225–230 (2010).
  • Oh SY , JuY, ParkH. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides. Mol. Cells28(4) , 341–345 (2009).
  • Marchelli R , CorradiniR, ManicardiA et al. Gene modulation by peptide nucleic acids (PNAs) targeting microRNAs (miRs). In: Targets in Gene Therapy. You Y (Ed.). InTech (2011).
  • Costa FF . Epigenomics in cancer management. Cancer Manag. Res.2 , 255–265 (2010).
  • Filipowicz W , JaskiewiczL, KolbFA, PillaiRS. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr. Opin. Struc. Biol.15 , 331–341 (2005).
  • He L , Hannon,GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet.5 , 522–531 (2010).
  • Kozomara A , Griffiths-JonesS. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res.39 , D152–D157 (2010).
  • Krol J , LoedigeI, FilipowiczW. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet.11 , 597–610 (2010).
  • Calabretta A , TedeschiT, CorradiniR, MarchelliR, Sforza,S. DNA and RNA binding properties of an arginine-based ‘extended chiral box‘ peptide nucleic acid. Tetrahedron Lett.52 , 300–304 (2011).
  • Borgatti M , RomanelliA, SavianoM et al. Resistance of decoy PNA–DNA chimeras to enzymatic degradation in cellular extracts and serum. Oncol. Res. 13(5) , 279–287 (2003).
  • Borgatti M , BredaL, CortesiR et al. Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-κB transcription factors. Biochem. Pharmacol. 64 , 609–616 (2002).
  • Demidov VV , PotamanVN, Frank-KamenetskiiMD et al. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol. 48(6) , 1310–1313 (1994).
  • Eriksson M , NielsenPE. PNA-nucleic acid complexes. Structure, stability and dynamics. Q. Rev. Biophys.29(4) , 369–394 (1996).
  • Shiraishi T , HamzaviR, NielsenPE. Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells. Nucleic Acids Res.36(13) , 4424–4432 (2008).
  • Gambari R , BorgattiM, BezzerriV et al. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor κB: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. Biochem. Pharmacol. 80(12) , 1887–1894 (2010).
  • Stein CA . Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments. Biochim. Biophys. Acta1489 , 45–52 (1999).
  • Hatamoto M , OhashiA, ImachiH. Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology. Appl. Microbiol. Biotechnol.86(2) , 397–402 (2010).
  • Pandey VN , UpadhyayA, ChaubeyB. Prospects for antisense peptide nucleic acid (PNA) therapies for HIV. Expert Opin. Biol. Ther.9(8) , 975–989 (2009).
  • Turner JJ , JonesS, FabaniMM, IvanovaG, ArzumanovAA, GaitMJ. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Mol. Dis.38(1) , 1–7 (2007).
  • Lundin KE , GoodL, StrömbergR, GräslundA, SmithCI. Biological activity and biotechnological aspects of peptide nucleic acid. Adv. Genet.56 , 1–51 (2006).
  • Yin H , BettsC, SalehAF et al. Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse. Mol. Ther. 18(4) , 819–827 (2010).
  • Shiraishi T , EysturskarthJ, NielsenPE. Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions. BMC Cancer10 , 342 (2010).
  • Tonelli R , PurgatoS, CamerinC et al. Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis. Mol. Cancer Ther. 4(5) , 779–786 (2005).
  • M⊘llegaard NE , BuchardtO, EgholmM, NielsenPE. Peptide nucleic acid.DNA strand displacement loops as artificial transcription promoters. Proc. Natl Acad. Sci. USA91(9) , 3892–3895 (1994).
  • Mischiati C , BorgattiM, BianchiN et al. Interaction of the human NF-κB p52 transcription factor with DNA–PNA hybrids mimicking the NF-κB binding sites of the human immunodeficiency virus type 1 promoter. J. Biol. Chem. 274(46) , 33114–33122 (1999).
  • Saviano M , RomanelliA, BucciE et al. Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-κB binding sites. J. Biomol. Struct. Dyn. 18(3) , 353–362 (2000).
  • Borgatti M , LamprontiI, RomanelliA et al. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)–DNA chimera mimicking Sp1 binding sites. J. Biol. Chem. 278(9) , 7500–7509 (2003).
  • Piva R , GambariR. Transcription factor decoy (TFD) in breast cancer research and treatment. Technol. Cancer Res. Treat.1(5) , 405–416 (2002).
  • Penolazzi L , BorgattiM, LambertiniE et al. Peptide nucleic acid-DNA decoy chimeras targeting NF-κB transcription factors: induction of apoptosis in human primary osteoclasts. Int. J. Mol. Med. 14(2) , 145–152 (2004).
  • Gambari R . Biological activity and delivery of peptide nucleic acids (PNA)–DNA chimeras for transcription factor decoy (TFD) pharmacotherapy. Curr. Med. Chem.11(10) , 1253–1263 (2004).
  • Borgatti M , FinottiA, RomanelliA et al. Peptide nucleic acids (PNA)–DNA chimeras targeting transcription factors as a tool to modify gene expression. Curr. Drug. Targets 5(8) , 735–744 (2004).
  • Borgatti M , BoydDD, LamprontiI et al. Decoy molecules based on PNA–DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoter. Oncol. Res. 15(7–8) , 373–383 (2005).
  • Romanelli A , PedoneC, SavianoM, BianchiN, BorgattiM, MischiatiC et al. Molecular interactions with nuclear factor κB (NF-κB) transcription factors of a PNA-DNA chimera mimicking NF-κB binding sites. Eur. J. Biochem. 268 , 6066–6075 (2001).
  • Cortesi R , MischiatiC, BorgattiM et al. Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles. AAPS J. 6(1) , 10–21 (2004).
  • Mischiati C , SereniA, FinottiA et al. Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity. J. Biomed. Sci. 11(5) , 697–704 (2004).
  • Nastruzzi C , CortesiR, EspositoE et al. Liposomes as carriers for DNA-PNA hybrids. J. Control. Release 68(2) , 237–249 (2000).
  • Wojciechowski F , HudsonRH. Nucleobase modifications in peptide nucleic acids. Curr. Top Med. Chem.7(7) , 667–679 (2007).
  • Hansen ME , BentinT, NielsenPE. High-affinity triplex targeting of double stranded DNA using chemically modified peptide nucleic acid oligomers. Nucleic Acids Res.37(13) , 4498–4507 (2009).
  • Manicardi A , CalabrettaA, BencivenniM et al. Affinity and selectivity of C2- and C5-substituted ‘chiral-box‘ PNA in solution and on microarrays. Chirality 22(Suppl. 1) , E161–E172 (2010).
  • Berthold PR , ShiraishiT, NielsenPE. Cellular delivery and antisense effects of peptide nucleic acid conjugated to polyethyleneimine via disulfide linkers. Bioconjug. Chem.21(10) , 1933–1938 (2010).
  • Pensato S , SavianoM, BianchiN et al. γ-hydroxymethyl PNAs: synthesis, interaction with DNA and inhibition of protein/DNA interactions. Bioorg. Chem. 38(5) , 196–201 (2010).
  • Zhou P , Dragulescu-AndrasiA, BhattacharyaB et al. Synthesis of cell-permeable peptide nucleic acids and characterization of their hybridization and uptake properties. Bioorg. Med. Chem. Lett. 16 , 4931–4935 (2006).
  • Zhou P , WangMM, DuL, FisherGW, WaggonerA, LyDH. Novel binding and efficient cellular uptake of guanidine-based peptide nucleic acids (GPNA). J. Am. Chem. Soc.125 , 6878–6879 (2003).
  • Rasmussen FW , BendifallahN, ZacharV et al. Evaluation of transfection protocols for unmodified and modified peptide nucleic acid (PNA) oligomers. Oligonucleotides 16 , 43–57 (2006).
  • Joergensen M , Agerholm-LarsenB, NielsenPE, GehlJ. Efficiency of cellular delivery of antisense peptide nucleic acid by electroporation depends on charge and electroporation geometry. Oligonucleotides21 , 29–37 (2011).
  • Shiraishi T , NielsenPE. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization. Methods Mol. Biol.683 , 391–397 (2011).
  • Sontheimer EJ , CarthewRW. Silence from within: endogenous siRNAs and miRNAs. Cell122 , 9–12 (2005).
  • Subramanian S , SteerCJ. MicroRNAs as gatekeepers of apoptosis. J. Cell. Physiology223 , 89–98 (2010).
  • Wang YM , BlellochR. Cell cycle regulation by MicroRNAs in embryonic stem cells. Cancer Res.69 , 4093–4096 (2010).
  • Alvarez-Garcia I , MiskaEA. MicroRNA functions in animal development and human disease. Development132 , 4653–4662 (2005).
  • Taccioli C , FabbriE, VisoneR et al. UCbase&miRfunc: a database of ultraconserved sequences and microRNA function. Nucleic Acids Res. 37(Database issue) , D41–D48 (2009).
  • Brown BD , NaldiniL. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet.10 , 578–585 (2009).
  • Czech MP . MicroRNAs as therapeutic targets. N. Engl. J. Med.354 , 1194–1195 (2006).
  • Kota SK , BalasubramanianS. Cancer therapy via modulation of microRNA levels: a promising future. Drug Discov. Today15 , 733–740 (2010).
  • Wang Z . MicroRNA interference: an update. J. Biol. Med.1 , 1–12 (2011).
  • Torres AG , FabaniMM, VigoritoE, GaitMJ. MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection. RNA17 , 933–943 (2011).
  • Elmén J , LindowM, SchützS, LawrenceM, PetriA, ObadS, et al. LNA-mediated microRNA silencing in non-human primates. Nature452 , 896–900 (2008).
  • Elmén J , LindowM, SilahtarogluA, BakM, ChristensenM, Lind-ThomsenA. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to upregulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res.36 , 1153–1162 (2008).
  • Krutzfeldt J , KuwajimaS, BraichR, RajeevK.G, Pena J et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res.35 , 2885–2892 (2007).
  • Krützfeldt J , RajewskyN, BraichR et al. Silencing of microRNAs in vivo with ‘antagomirs‘. Nature 438 , 685–689 (2005).
  • López-Fraga M , WrightN, JiménezA. RNA interference-based therapeutics: new strategies to fight infectious disease. Infect. Disord. Drug Targets8 , 262–273 (2008).
  • Zhiguo W . MicroRNA interference: an update. J. Biol. Med.1(1) , 1–12 (2011).
  • Boutla A , DelidakisC, TablerM. Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Res.31(17) , 4973–4980 (2003).
  • Meister G , LandthalerM, DorsettY, TuschlT. Sequence-specific inhibition of microRNA- and siRNA-induced. RNA silencing. RNA10(3) , 544–550 (2004).
  • Krtzfeldt J , RajewskyN, BraichR et al. Silencing of microRNAs in vivo with ‘antagomirs‘. Nature 438(7068) , 685–689 (2005).
  • Krtzfeldt J , KuwajimaS, BraichR et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 35(9) , 2885–2892 (2007).
  • Kauppinen S , LundAH. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene372 , 137–141 (2006).
  • Davis S , LolloB, FreierS, EsauC. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res.34(8) , 2294–2304 (2006).
  • Fabani MM , GaitMJ. miR-122 targeting with LNA/2´-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA–peptide conjugates. RNA14(2) , 336–346 (2008).
  • Clancy JL , WeiGH, EchnerN et al. mRNA isoform diversity can obscure detection of miRNA-mediated control of translation. RNA 17(6) , 1025–1031 (2011).
  • Lee EK , GorospeM. Coding region: the neglected post-transcriptional code. RNA Biol.8(1) , 44–48 (2011).
  • Wang Z . The concept of multiple-target anti-miRNA antisense oligonucleotide technology. Methods Mol. Biol.676 , 51–57 (2011).
  • Torres AG , ThrelfallRN, GaitMJ. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2‘-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents. Artif. DNA PNA XNA2(3) , 1–8 (2011).
  • Petersen L , de Koning MC, van Kuik-Romeijn P et al. Synthesis and in vitro evaluation of PNA-peptide-DETA conjugates as potential cell penetrating artificial ribonucleases. Bioconjug. Chem.15(3) , 576–582 (2004).
  • Tyagi P , BanerjeeR, BasuS, YoshimuraN, ChancellorM, HuangL. Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates. Mol. Pharm.3(4) , 398–406 (2006).
  • Frederickson R . PNA–NLS delivers. Nat. Biotechnol.17(8) , 739 (1999).
  • Albertshofer K , SiwkowskiAM, WancewiczEV et al. Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acid. J. Med. Chem. 48(21) , 6741–6749 (2005).
  • Leifert JA , WhittonJL. ‘Translocatory proteins‘ and ‘protein transduction domains‘: a critical analysis of their biological effects and the underlying mechanisms. Mol. Ther.8(1) , 13–20 (2003).
  • Chaubey B , TripathiS, GangulyS, HarrisD, CasaleRA, PandeyVN. A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties. Virology331(2) , 418–428 (2005).
  • Braun K , PeschkeP, PipkornR et al. A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J. Mol. Biol. 318(2) , 237–243 (2002).
  • Basu S , WickstromE. Synthesis and characterization of a peptide nucleic acid conjugated to a d-peptide analog of insulin-like growth factor 1 for increased cellular uptake. Bioconjug. Chem.8(4) , 481–488 (1997).
  • Abes S , TurnerJJ, IvanovaGD et al. Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Res. 35(13) , 4495–4502 (2007).
  • Mehiri M , UpertG, TripathiS et al. An efficient biodelivery system for antisense polyamide nucleic acid (PNA). Oligonucleotides 18(3) , 245–256 (2008).
  • Berg K , FoliniM, PrasmickaiteL et al. Photochemical internalization: a new tool for drug delivery. Curr. Pharm. Biotechnol. 8(6) , 362–372 (2007).
  • Shiraishi T , NielsenPE. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption. Nat. Protoc.1(2) , 633–636 (2006).
  • Qavi AJ , BaileyRC. Multiplexed detection and label-free quantitation of microRNAs using arrays of silicon photonic microring resonators. Angew. Chem. Int. Ed. Engl.49(27) , 4608–4611 (2010).
  • Zhang GJ , ChuaJH, CheeRE, AgarwalA, WongSM. Label-free direct detection of miRNAs with silicon nanowire biosensors. Biosens. Bioelectron.24(8) , 2504–2508 (2009).
  • Pfeffer S , BaumertTF. Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection. Gastroenterol. Clin. Biol.34(8–9) , 431–435 (2010).
  • Young DD , ConnellyCM, GrohmannC, DeitersA. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J. Am. Chem. Soc.132(23) , 7976–7981 (2010).
  • Morita K , TaketomiA, ShirabeK et al. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int. 31(4) , 474–484 (2011).
  • Lanford RE , Hildebrandt-EriksenES, PetriA et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962) , 198–201 (2010).
  • Tili E , CroceCM, MichailleJJ. miR-155: on the crosstalk between inflammation and cancer. Int. Rev. Immunol.28(5) , 264–284 (2009).
  • Kong W , HeL, CoppolaM et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J. Biol. Chem. 285(23) , 17869–17879 (2010).
  • Jiang S , ZhangHW, LuMH et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 70(8) , 3119–3127 (2010).
  • Bianchi N , ZuccatoC, LamprontiI, BorgattiM, GambariR. Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB Rep.42(8) , 493–499 (2009).
  • Yan LX , WuQN, ZhangY et al. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res. 13(1) , R2 (2011).
  • Chaubey B , TripathiS, PandeyVN. Single acute-dose and repeat-doses toxicity of anti-HIV-1 PNA TAR-penetratin conjugate after intraperitoneal administration to mice. Oligonucleotides18(1) , 9–20 (2008).
  • Ganguly S , ChaubeyB, TripathiS et al. Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element. Oligonucleotides 18(3) , 277–286 (2008).
  • Corradini R , SforzaS, TedeschiT, TotsinganF, ManicardiA, MarchelliR. Peptide nucleic acids with a structurally biased backbone. Updated review and emerging challenges. Curr. Top Med. Chem.11(12) , 1535–1554 (2011).
  • Sahu B , SacuiI, RapireddyS et al. Synthesis and characterization of conformationally preorganized, (R)-diethylene glycol-containing γ-peptide nucleic acids with superior hybridization properties and water solubility. J. Org. Chem. 76(14) , 5614–5627 (2011).
  • Wojciechowski F , HudsonRH. Peptide nucleic acid containing a meta-substituted phenylpyrrolocytosine exhibits a fluorescence response and increased binding affinity toward RNA. Org. Lett.11(21) , 4878–4881 (2009).
  • Govindaraju T , MadhuriV, KumarVA, GaneshKN. Cyclohexanyl peptide nucleic acids (chPNAs) for preferential RNA binding: effective tuning of dihedral angle beta in PNAs for DNA/RNA discrimination. J. Org. Chem.71(1) , 14–21 (2006).
  • Sforza S , TedeschiT, CalabrettaA et al. A peptide nucleic acid embedding a pseudo peptide nuclear localization sequence in the backbone bahaves as a peptide mimic. Eur. J. Org. Chem. 13 , 2441–2444 (2010).
  • Ishizuka T , TedeschiT, CorradiniR, KomiyamaM, SforzaS, MarchelliR. SSB-assisted duplex invasion of preorganized PNA into double-stranded DNA. Chem. Bio. Chem.10(16) , 2607–2612 (2009).
  • Ishizuka T , YoshidaJ, YamamotoY et al. Chiral introduction of positive charges to PNA for double-duplex invasion to versatile sequences. Nucleic Acid Res. 36(5) , 1464–1471 (2008).
  • Yuan X , MaZ, ZhouW et al. Lipid-mediated delivery of peptide nucleic acids to pulmonary endothelium. Biochem. Biophys. Res. Commun. 302(1) , 6–11 (2003).
  • Cutrona G , BoffaLC, MarianiMR et al. The peptide nucleic acid targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt‘s lymphoma lacks immunogenicity: follow-up characterization of PNAEmu-NLS. Oligonucleotides 17(1) , 146–150 (2007).
  • Ahn DG , LeeW, ChoiJK et al. Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication. Antiviral Res. 91(1) , 1–10 (2011).
  • Upadhyay A , PonzioNM, PandeyVN. Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome. Oligonucleotides18 , 329–336 (2008).

Patents

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.